Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2022 07:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

PDUFA action date set for October 8, 2022 Company preparing for Q4 commercial launch, if approved BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a...
April 11, 2022 07:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

BURLINGTON, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
March 22, 2022 07:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Successfully completed all testing; plan to re-submit FUROSCIX® NDA by April 15, 2022 Commercial preparedness activities ramping up to support anticipated Q4 2022 launch of FUROSCIX, if approved ...
February 16, 2022 16:05 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

BURLINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
February 03, 2022 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

BURLINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
December 20, 2021 16:05 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
November 09, 2021 07:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

All additional testing of devices manufactured on the planned commercial line, as required by the FDA, has been successful to date FUROSCIX® NDA resubmission anticipated for Q1 2022 due to COVID-19...
November 02, 2021 08:30 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the Jefferies London Healthcare Conference

BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
September 10, 2021 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021

Data show statistically significant and meaningful reduction in both heart failure-related and overall healthcare costs for patients treated with FUROSCIX® versus a historical comparator group ...
September 01, 2021 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...